Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6106 to 6120 of 7682 results

  1. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of pharmacological management of heart failure for adults with heart failure and severe aortic stenosis, severe aortic regurgitation or severe mitral regurgitation?

    Recommendation ID NG208/18 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  2. Effectiveness of SGLT2 inhibitors for different ethnic groups: What is the clinical and cost effectiveness of SGLT2 inhibitors in adults with type 2 diabetes and chronic kidney disease, stratified across different ethnic groups?

    Recommendation ID NG28/05 Question Effectiveness of SGLT2 inhibitors for different ethnic groups: What is the clinical and cost effectiveness

    Research recommendation
    Published
    24 March 2022

  3. Post-discharge early follow-up clinics:- What is the clinical and cost effectiveness of post-discharge early follow-up clinics for people who have had a medical emergency and are at risk of unscheduled hospital readmission? [See the evidence review on post-discharge early follow-up clinics.]

    Recommendation ID NG94/16 Question Post-discharge early follow-up clinics:- What is the clinical and cost effectiveness of post-discharge

    Research recommendation
    Published
    15 November 2018

  4. Effectiveness of SGLT2 inhibitors for adults with a urine ACR below 3 mg/mmol: What is the clinical and cost effectiveness of SGLT2 inhibitors in adults with type 2 diabetes, chronic kidney disease and a urine ACR of less than 3 mg/mmol?

    Recommendation ID NG28/06 Question Effectiveness of SGLT2 inhibitors for adults with a urine ACR below 3 mg/mmol: What is the clinical

    Research recommendation
    Published
    24 March 2022

  5. Same-day hospital specialist assessment: Which people with extreme hypertension (220/120 mmHg or higher) or emergency symptoms should be referred for same-day hospital specialist assessment?

    Recommendation ID NG136/06 Question Same-day hospital specialist assessment: Which people with extreme hypertension (220/120 mmHg or higher)

    Research recommendation
    Published
    11 April 2022

  6. Primary care-led assessment models:- Which primary care-led models of assessment of people with a suspected medical emergency in the community, such as GP home visits, are most clinically and cost effective? [See the evidence review on GP-led home visits.]

    Recommendation ID NG94/8 Question Primary care-led assessment models:- Which primary care-led models of assessment of people with a suspected

    Research recommendation
    Published
    15 November 2018

  7. Signs and symptoms of Kawasaki disease: Which signs and symptoms (or combinations of signs and symptoms) predict a diagnosis of Kawasaki disease in children under 5 presenting with fever lasting 5 days or more?

    Recommendation ID NG143/08 Question Signs and symptoms of Kawasaki disease: Which signs and symptoms (or combinations of signs and symptoms)

    Research recommendation
    Published
    17 December 2021

  8. What is the effectiveness, cost effectiveness and acceptability of the whole family approach to carers' assessments?

    Recommendation ID NG150/1 Question What is the effectiveness, cost effectiveness and acceptability of the whole family approach to carers'

    Research recommendation
    Published
    10 February 2020

  9. What is the efficacy and cost effectiveness of rehabilitation services compared with treatment as usual for people with complex psychosis with residual disability, who are leaving early intervention services?

    Recommendation ID NG181/1 Question What is the efficacy and cost effectiveness of rehabilitation services compared with treatment as usual

    Research recommendation
    Published
    26 October 2020

  10. Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic assessment and intervention for people living with high levels of multimorbidity?

    Recommendation ID NG56/2 Question Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic

    Research recommendation
    Published
    18 October 2016

  11. What is the effectiveness and cost effectiveness of different scheduling of zoledronic acid in the prevention and reduction of skeletal events in people with hormone-refractory prostate cancer?

    Recommendation ID NG131/8 Question What is the effectiveness and cost effectiveness of different scheduling of zoledronic acid in the prevention

    Research recommendation
    Published
    25 October 2019

  12. Further research should ideally be in the form of randomised controlled trials. Details of patient selection, the procedure and long-term outcomes should be reported.

    Recommendation ID IPG766 Question Further research should ideally be in the form of randomised controlled trials. Details of patient selection

    Research recommendation
    Published
    7 August 2023

  13. What structured group activities are effective at improving interpersonal functioning (social skills) for people with complex psychosis?

    Recommendation ID NG181/4 Question What structured group activities are effective at improving interpersonal functioning (social skills)

    Research recommendation
    Published
    26 October 2020

  14. What is the most clinical and cost-effective strategy, as identified by a consensus survey, for the perioperative management of anticoagulation treatment in people taking a vitamin K antagonist with a target international normalised ratio (INR) of more than 3 who need bridging therapy?

    Recommendation ID NG180/3 Question What is the most clinical and cost-effective strategy, as identified by a consensus survey, for the

    Research recommendation
    Published
    26 October 2020

  15. For how long should a person who has received emergency treatment for anaphylaxis be observed?

    Recommendation ID CG134/3 Question For how long should a person who has received emergency treatment for anaphylaxis be observed?

    Research recommendation
    Published
    26 October 2020